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 ABSTRACT  
 
Title: Correlates of delayed pulmonary tuberculosis diagnosis among HIV- 
infected pulmonary tuberculosis suspects in rural HIV clinic in South Africa 
 
Background 
South Africa is among the countries most heavily affected by Human 
Immunodeficiency Virus (HIV) and tuberculosis. Delay in pulmonary tuberculosis 
(PTB) diagnosis is more prevalent in HIV-positive patients and is one of the 
factors associated with the high prevalence of co-infection in this population. This 
study sought to determine factors associated with delayed PTB diagnosis among 
HIV-infected PTB suspects attending an HIV/AIDS clinic in rural South Africa. 
 
Methods 
This was a secondary analysis of the data collected in a retrospective cohort 
study conducted by Rural Aids and Development Action Research Programme 
(RADAR). Data were collected using record review of patients assessed as PTB 
suspects over 2 years from January 2006 to December 2007 at Rixile clinic.  TB 
diagnosis delay was defined as PTB diagnosis after 8 weeks (56 days) from the 
date of first sputum for acid fast bacilli (AFB) collection, taking into account those 
diagnosed by culture as it takes up to 8 weeks to culture mycobacterium 
tuberculosis using Lowenstein Jensen method. 
 Results 
PTB diagnosis delay was found in 78/162 (48.15%) of the participants with 
subsequent TB diagnosis. Median delay was 55 days (IQR = 20 – 302). The 
delay was between 1 to 30 days in 27/78 (34.62%) participants, between 31 to 
180 days in 26/78 (33.33%) participants and 25/78 (32.05%) participants 
remained undiagnosed for more than 180 days. Factors predicting PTB diagnosis 
delay in multivariate analysis were older age > 40 years (adjusted OR 3.43 
95%CI 1.38 – 8.55, p=0.008), high HIV viral-load (adjusted OR 3.13 95%CI 1.13 
– 8.71, p=0.03) and being on Antiretroviraltherapy (ART) at the time of PTB 
diagnosis (adjusted OR 4.19 95%CI 1.66 – 10.58, p=0.002). 
 
Conclusion 
There is a considerable delay from PTB suspicion to diagnosis in these rural HIV-
infected patients. Older patients, those with elevated viral load and those who are 
on ART at the time of PTB diagnosis are at higher risk of PTB diagnosis delay. 
Therefore active and collaborative efforts to reduce the PTB diagnosis delay are 
very essential. 
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CHAPTER ONE 
1 INTRODUCTION 
In this chapter the general overview of tuberculosis and HIV/AIDS is covered. 
The problem statement is stated and the research justification. The published 
literatures on TB/HIV co-infection and factors associated with tuberculosis 
diagnosis and treatment delay are reviewed and the chapter ends with the 
definition of terms and objectives of the study described in this research report. 
 
1.1 Background 
It is estimated that one third of the world’s population are infected with 
tuberculosis. Tuberculosis (TB) is still one of the biggest killers among infectious 
diseases reported in World Health Organization. The global burden of 
tuberculosis remains high, mainly because of poor control in Southeast Asia, 
Sub-Saharan Africa and Eastern Europe, and because of high rates of 
mycobacterium tuberculosis and HIV co-infection in some African countries (1). 
The HIV epidemic has aggravated tuberculosis situation in the world. It increases 
the risk of reactivation of latent tuberculosis, it also causes a more rapid 
progression of tuberculosis disease. HIV alters the clinical presentation of 
tuberculosis and compromises the response to anti-TB treatment. People with 
both HIV and tuberculosis are likely to die far earlier than those HIV patients 
 without tuberculosis. Likewise, TB patients with HIV infection are more likely to 
die earlier than TB patients who do not have an HIV infection (2). 
Approximately 11% of sub-Saharan African adults are infected with HIV; this has 
caused TB cases to rise in sub-Saharan African countries. WHO (2007) 
estimates that the average incidence of TB in sub-Saharan African countries 
more than doubled between 1990 and 2005, from 149 to 343 per 100,000 
population (3). 
Recognizing the scale of the problem, in 2006, the World Health Organization 
launched the “Stop TB Strategy” (4) as the internationally recommended 
approach to reducing the burden of TB. The stop TB strategy was developed as 
the successor to the DOTS (Directly Observed Therapy, Short Course) strategy. 
The goal of the strategy is defined as: “To dramatically reduce the global burden 
of TB by 2015 in line with the Millennium Development Goals and the Stop TB 
Partnership targets”. The strategy has six major components: 
1. Pursue high-quality DOTS expansion and enhancement; 
2. Address TB/HIV, MDR-TB, and the needs of poor and vulnerable populations; 
3. Contribute to health system strengthening based on primary health care; 
4. Engage all care providers; 
5. Empower people with TB, and communities through partnership; 
6. Enable and promote research. 
 South Africa is among the countries most heavily affected by HIV and 
tuberculosis. An estimated 31% of all TB-HIV co-infection cases reported in 
Africa are in South Africa and tuberculosis rate in South Africa is ranked fifth 
highest among 22 countries with a high burden of tuberculosis. It is the second 
most serious infectious disease and has been made a priority program by the 
National Department of Health (5). 
Along with HIV, another factor aggravating this public health problem is delay in 
pulmonary tuberculosis diagnosis and treatment. Delay in PTB diagnosis causes 
the disease to advance, results in more complications and leads to a higher 
mortality at the individual level and transmission within the community (6). One 
infectious TB case can infect up to 15 other people in the course of one year (7). 
For those patients co-infected with HIV mycobacterium tuberculosis causes 
increase in viral load making them more likely to transmit HIV and rapidly 
progressing immune suppression (8). 
TB control programmes in Africa rely predominantly on passive case findings and 
diagnostics for TB are limited to sputum microscopy. Sputum testing is often 
ineffective among  TB/HIV co-infected patients who are more likely to be sputum 
smear negative, atypical radiographic findings, higher prevalence of extra-
pulmonary tuberculosis and resemblance to other opportunistic infections (9). 
This may contribute to the delay in pulmonary tuberculosis diagnosis in HIV 
infected patients, hence poor health outcomes and increases public risk of 
possible exposure to TB in the community without treatment.   
 Three essential activities that all HIV programmes should be doing to protect 
people with HIV from TB infection are; Aggressive TB screening which can lead 
to early diagnosis and prompt TB treatment initiation, Isoniazid preventive 
therapy to reduce the risk of developing active TB, and practicing TB infection 
control to reduce the spread of TB to vulnerable people with HIV, health care 
workers and the community (10). Therefore, a strong co-ordination between the 
national TB and the AIDS control programmes is required for effective 
management of HIV-TB patients. 
 
 
 
 
 
 
 
 
 
 
 
 1.2 Problem Statement. 
The burden of tuberculosis is increasing globally. HIV epidemic has emerged as 
the most important predisposing factor for developing TB, and the burden of 
TB/HIV co-infection in South Africa is very high.  
Delay in pulmonary tuberculosis diagnosis is more prevalent in HIV positive 
patients and is one of the factors associated with the high prevalence of co-
infection in this population.  
Undiagnosed TB accelerates the clinical course of HIV disease leading to poor 
patient’s health outcome. Lack of TB diagnosis and treatment may also put more 
people with HIV and unrecognised TB at risk of serious immune reconstitution 
inflammatory reactions, when they are put on ART, and could be a factor in high 
mortality on ART. It also increases the cost both to patient and health care 
system due to additional clinic visits and the need for hospitalization. 
Few studies have been conducted in developing countries, including South Africa 
to identify factors associated with the delay in pulmonary tuberculosis diagnosis 
among HIV infected patients. 
Addressing factors that influence time to pulmonary tuberculosis diagnosis 
among HIV-infected patients is vital to achieving the goal of reducing the global 
burden of tuberculosis. 
 
 
 1.3 Justification 
The goals of TB control are to reduce mortality, morbidity and transmission of the 
disease in the community.  
It is therefore important to reduce the TB diagnosis delay in order to improve 
patient’s health outcomes, reduce the infection duration in the community and 
thereby reduce the number of new infections. This requires exploration of factors 
influencing delay in PTB diagnosis. . 
This study presented here aimed to examine factors associated with delay in 
PTB diagnosis among HIV/AIDS patients following entry into public sector HIV 
services in rural South Africa. 
The results of this study will inform the evidence-base necessary to improve 
implementation and effectiveness of PTB investigations, with particular reference 
to a rural setting. 
 
 
 
 
 
 
 1.4 Literature review 
Globally, the burden of tuberculosis is increasing. Apart from HIV/AIDS, 
undiagnosed cases in the community increases the burden of tuberculosis, this 
can be due to patients delaying seeking healthcare or failure of the healthcare 
systems to diagnose patients in a timely manner (11). Patient’s health seeking 
behaviour and factors within the healthcare systems are the main determinants 
of the delay. 
 
TB diagnosis delay time 
There is no general agreement for how long acceptable delays could be. For 
effective TB control, it is generally considered that, the time from the onset of 
symptoms to the first contact with a qualified health provider should not be more 
than 2 or 3 weeks, and the time from first contact to the start of treatment should 
be only a few days (12). Various studies have reported about the delays in 
diagnosis of tuberculosis in high, middle and low income countries. 
An overall management delay of up to 25 days among hospitalized patients with 
tuberculosis, was reported in Washington USA (13), whereas Golub et al (14) 
found the median heath care delay of 26 days among patients who were reported 
to the Maryland Department of Health and Mental Hygiene.  Farah et al (15) 
reported the median health care system delay of 33 days in Norway. 
Chandrashekhar et al (16) in a systematic review reported that, among high 
income countries health care system delay ranged from a shortest of 7 days in 
 Japan to a longest of 36 days in Italy, whereas among low and middle income 
countries health care system delay ranged from shortest of 2 days in China to a 
longest of 87 days in Pakistan. 
Median health care system delay of 22 days was reported in Sarawak, Malaysia 
(17), other studies have reported median health system delays of 24, 18 and 28 
days from China, Nepal and India respectively (18-20).  
Studies conducted in Africa have reported the median diagnostic delays of 15, 12 
and 9 weeks from Tanzania, Uganda and Zambia respectively (21-23). Other 
studies have reported median diagnostic delays of 9, 8 and 5 weeks from 
Gambia, Ghana and Kenya respectively (24-26). Tatek et al (27) reported a 
median health system delay of 6 weeks in Ethiopia, patients from urban areas 
had shorter health system delay than patients from rural areas. Meintjes et al 
(28), reported a median total delay from the onset of symptoms to treatment of 8 
weeks at G F Jooste Hospital, Cape Town, whereas Pronyk et al (29) reported a 
median total delay of 10 weeks in Bushbuckridge region, Mpumalanga province 
of South Africa. 
 
 
Socio-demographic determinants  
Most studies conducted in high, middle and low income countries have reported 
old age to be a risk factor for increased diagnostic delay (14-16, 23, 26). Elderly 
 patients often have co-existing medical conditions like heart diseases and 
chronic chest problems, which makes it more difficult to diagnose TB and can 
result in diagnosis and treatment delay. 
Females have been reported to be at risk of diagnostic delay in most studies 
conducted in middle and low income countries (18-22). Several factors have 
been associated with increased diagnostic delay among females, some being 
cultural, social, low social economic status of women and women’s tendency of 
placing family matters above their own health. In some communities, female TB 
patients and women who are suspected to have active TB are likely to be forced 
to get divorced and have fewer chances of getting married (30). Pronky et al (29) 
reported increased diagnostic delay among females in rural South Africa, 
whereas Meintjes et al (30) reported increased diagnostic delay among males in 
Cape Town, South Africa. 
 
Socio-economic determinants  
Low income and poverty have been reported to be associated with increased 
diagnostic delay in several studies conducted in middle and low income 
countries. Studies have found that financial difficulties account for delay in China 
(18). Transportation costs, which are associated with distance between 
residence and healthcare facility accounts for the delay in Zambia (23). 
Diagnostic delay is more likely when patients don’t have health insurance or 
money to attend healthcare facility. 
 Being knowledgeable and perceived risk of TB within communities, influence the 
tendency to seek care. A number of studies have found association between 
knowledge and delayed diagnosis. As demonstrated in Tanzania, India and 
Vietnam (21, 20, 30), patients with low knowledge about the disease are more 
likely to postpone care seeking. It is also reported in study from Tanzania that, 
patients with low knowledge are more likely to visit traditional healers rather than 
a recognized health facility. Low education and knowledge about the disease, 
contributes to beliefs that TB is incurable, caused by evil spirits and stigma as it 
has been reported in a study conducted in Pwani region, Tanzania (31). Size of 
the households can also influence health care seeking behaviour. Pronky et al 
(29), reported that patients who came from larger households had significantly 
shorter delays in Bushbuckridge, South Africa. This is due to substantial 
influence of family members in motivating health seeking behaviour. 
 
 
Health system determinants 
Health care providers are expected to adequately and timely conduct patients 
examination and investigations. However inadequate TB knowledge among 
health workers and lack of diagnostic facilities may delay patient’s diagnosis and 
treatment (32). Studies have reported that, TB diagnosis is often inadequate in 
primary health centres that have limited diagnostic facilities and poorly trained 
personnel especially in rural areas. Private practitioners with low awareness of 
 TB have also been reported to be risk factors for prolonged health system delay 
(33-34). This often results in patients repeated consultation of healthcare 
providers without a correct diagnosis. 
A study to explore the ways in which provider and patient behaviour interact to 
exacerbate diagnostic delay in Cape Town, South Africa revealed diagnostic 
delay to be caused by, provider failure to diagnose TB at first contact, use of 
private sector which did not treat TB and multiple care seeking within and 
between sectors. Findings of this study suggest the need for strategies to 
encourage patients to visit their local public clinics, additional training or 
information about diagnosis and referral for private doctors and strategies to 
smooth the flow of patients within and between sectors will reduce diagnostic 
delay (35). 
Missed chest X-ray at first visit has been reported to result in longer delays in 
diagnosis (36). Golub et al (14) in Maryland revealed, initially presenting to a 
private physician, not receiving a chest X-ray, not providing a sputum specimen 
at the initial  health care visit  and being diagnosed with another respiratory 
illness or receiving non-TB antibiotic therapy was associated with prolonged 
health system delay. The under – utilisation of smear microscopy, sputum culture 
or chest X-ray in the diagnosis of TB is associated with prolonged health system 
delay (37-38). 
 
 
 TB diagnosis delay in HIV infected patients 
Delay in diagnosis and treatment of tuberculosis increases mortality in HIV 
infected patients. Tuberculosis accelerates the progression HIV infection, leads 
to high viral load, lower CD4 count (less than 200cells/mm3) and increases the 
risk of mortality in HIV/AIDS patients (39-40). To improve the diagnosis, 
treatment and outcomes for patients with both diseases, the World Health 
Organization developed a framework of strategic collaborative activities to be 
performed as part of the health sector response to control HIV infection related 
TB. These activities include measures to decrease burden of TB among persons 
with HIV infection, and to decrease the burden of HIV infection among persons 
with TB (41). 
Tuberculosis in HIV infected patients is often difficult to diagnose because of 
nonspecific symptoms, atypical or normal chest radiographic findings, negative 
results of sputum smear microscopy and lack of culture facilities in resource 
limited settings (42). This often results in delay in TB diagnosis in HIV infected 
patients. Undiagnosed tuberculosis in patients starting ART may result in 
morbidity during early ART because of immune reconstitution inflammatory 
syndrome (43), and increased mortality among patients on ART, as it has been 
reported in a previous study conducted in a source population of this study in 
which they noted a high TB related mortality among ART patients (44). 
Delay in TB diagnosis in HIV infected patients may results in TB transmission 
among other patients in HIV clinics and in communities. Tuberculosis in HIV 
 infected patients is more likely to be sputum smear negative TB, which is less 
infectious than patients with sputum smear positive TB (45). However, patients 
with smear negative, culture positive pulmonary TB are capable of transmitting 
mycobacterium tuberculosis (46). Therefore, persons in contact with patients with 
smear negative TB are at risk of infection due to mycobacterium tuberculosis and 
subsequent development of active TB (47).  
In high income countries, 10% to 20% of TB transmission at the population level 
is attributable to source cases with smear negative pulmonary TB (48). In Sub – 
Saharan Africa, the prevalence of undiagnosed TB, which is a key determinant of 
TB transmission, is very high, and the disease duration before diagnosis is 
prolonged (49). In a previous study conducted in Gugulethu Township, Cape 
Town, among all newly referred ART patients, found that more than twenty five 
percent of patients had culture confirmed pulmonary TB (48). Culture based 
diagnosis took more than 3 weeks, on average. This increases the chance of TB 
transmission and is the risk factor for the outbreak of Multi-drug resistant TB 
(MDR-TB) and Extensively drug resistant TB (EDR-TB), like what happened at 
an ART clinic in Tugera Ferry, South Africa (50). This brought to the world’s 
attention that, urgent action is required to prevent, diagnose and treat TB in 
people living with HIV, their families and communities. 
Highly active antiretroviral therapy (HAART) has been shown to decrease the 
occurrence of HIV/AIDS associated tuberculosis. A study to determine the effect 
of HAART on incidence of tuberculosis in South Africa found a decrease in the 
occurrence of HIV/AIDS associated tuberculosis by more than 80% among 
 patients who were receiving HAART compared to those who were not receiving 
HAART. The result of this study supports the WHO recommendation to increase 
antiretroviral therapy throughout sub-Saharan Africa and world-wide (51). 
 
Conclusion 
In conclusion, long delays in TB diagnosis result in patients presenting with 
advanced disease and hence high mortality. Diagnostic delay increases the 
burden of tuberculosis by increasing the period of infectivity in the community. 
Measures should be taken to reduce delays in TB diagnosis, with attention paid 
to patient-related factors, such as raising awareness of TB in general population, 
stigma, use of traditional healers and health system factors such as failure to 
investigate for TB, extensive and irrational use of antibiotics and improving 
accessibility of health services. 
 
 
 
 
 
 
 
 1.5 Definition of terms 
Lag period- time from clinical suspicion of a pulmonary tuberculosis episode to 
diagnosis. 
PTB Diagnosis – a clinical diagnosis of pulmonary tuberculosis by a clinician or 
initiation of PTB treatment 
PTB suspects – Individuals suspected of having pulmonary tuberculosis 
infection from clinical presentation. 
Socio-demographic correlates - Are social and population factors (eg age, sex, 
marital status, place of residence). 
Clinical correlates – Are patient clinical presentation, clinicians and diagnostic 
factors. 
HAART: Highly active antiretroviral therapies are different combinations of drugs 
which work by reducing multiplication of HIV in people infected with the virus. 
PTB Diagnosis delay – As there is no scientifically agreed criteria for TB 
diagnosis delay definition which could be found in the literature, we defined TB 
diagnosis delay as PTB diagnosis after 8 weeks (56 days) from the date of first 
sputum for acid fast bacilli (AFB) collection, taking into account those diagnosed 
by culture as it takes up to 8 weeks to culture mycobacterium tuberculosis using 
Lowenstein Jensen method (52).  
 
 Recommended standard procedures applied to the diagnosis of TB in South 
Africa are summarized in figure 1 (53). 
 
 
                                                                                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: AFB is Acid Fast Bacilli 
 
 
FIGURE 1: TB diagnostic algorithm in South Africa 
 
 
 
Day 1- Take Sputum for microscopy (AFB)-On 
the spot 
Day 2- Take Sputum for microscopy (AFB) early 
in the morning 
e 
Both smears positive One smear positive Both smears negative 
Do chest X-ray Do chest X-ray 
Compatible with TB Normal Compatible with TB Normal 
Take 2 Sputum: 1 
Smear, 1 Culture 
1 
Smear or Culture positive  Smear and Culture negative 
Treat as new patient 
Reassess diagnosis 
 1.6 Research question 
What are the dynamics and factors associated with pulmonary tuberculosis 
diagnosis delay among HIV-infected pulmonary tuberculosis suspects? 
 
1.7 Objectives of the study 
Main objective 
The main objective of this study is to investigate correlates of delayed PTB 
diagnosis among HIV-infected PTB suspects in a rural HIV clinic in South Africa. 
 
Specific objectives 
The specific objectives of this study are: 
1. To determine the lag period to PTB diagnosis among PTB suspects 
attended at Rixile Clinic between January 2006 and December 2007. 
2. To examine socio-demographic and clinical correlates of delayed PTB 
diagnosis among PTB suspects attended at Rixile Clinic between January 
2006 and December 2007. 
3. To assess the relationship between ART initiation and the lag period to 
PTB diagnosis among PTB suspects attended at Rixile Clinic between 
January 2006 and December 2007. 
 CHAPTER TWO 
METHODS 
This study was conducted in order to determine factors associated with 
pulmonary tuberculosis diagnosis delay among HIV infected pulmonary 
tuberculosis suspects. In order to answer this research goal, secondary analysis 
of the data obtained from the primary study conducted by RADAR was done. 
This chapter gives an overview of the methodology, and the details about data 
collection and analysis. 
 
2.1 Study design 
This was a secondary analysis of the data collected in a retrospective cohort 
study conducted by Rural Aids and Development Action Research Programme 
(RADAR). Data were collected using record review of patients assessed as PTB 
suspects over 2 years from January 2006 to December 2007 at Rixile clinic.   
 
2.2 Study Setting 
The study was conducted at Rixile clinic a dedicated rural HIV clinic situated at 
Tintswalo hospital in Mpumalanga Province of South Africa. The clinic is 
operated jointly by the Department of Health and Perinatal HIV Research Unit. 
The clinic has enrolled over 5000 people living with HIV/AIDS, and a further 2000 
has been placed on HAART. The clinic is mainly nurse-driven and doctor-
 supported. The clinic attends to an average of 20 TB suspects per month. 
Diagnostic ability for TB is limited, yet many patients are not placed on isoniazide 
prophylaxis for fear of resistance and poor adherence. The area has been 
designated one of the 13 most rural nodes of South Africa. The population is 
predominantly black, Shangaan and SePedi-speaking, and largely poor with 
most households headed by women due to high levels of job migration. 
 
2.3 Study Population 
The study population comprised of adult PTB suspects co-infected with HIV 
identified by clinical symptoms and seen at Rixile Clinic, between January 2006 
and December 2007. The case definition was patients for whom Sputum Acid 
Fast Bacilli (AFB) test were requested by nurses and who appeared on the 
‘Specimen collection and treatment refill’ forms between January 2006 and 
December 2007. 
Inclusion criteria were: 
1. Chronic cough for at least two weeks 
2. Drenching Night sweats 
3. Loss of weight 
4. Loss of appetite 
       5.     18 years of age and above. 
 Exclusion criteria were: 
1. Suspected exclusive Extra-pulmonary TB (without PTB suspect) 
 
2.4 Sampling and sample size: 
Data on 452 participants enrolled by RADAR in a cohort study were used. The 
original primary study used TB suspect register to sample participants. In two 
years period 630 participants were identified from the TB suspect register. Sixty 
two participants were excluded from the study: 7 were under 18 years old, 39 
had no AFB investigation requested, 1had extra pulmonary TB, 15 had noTB 
diagnosis information. Eighty five participants’ medical records were missing and 
31 were duplicates. Therefore, 452 participants were included in the study, and 
PTB diagnosis delay predictors analysis was among 162 participants. Figure 2 
below summarizes the number of participants seen.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
**7-Under 18years old, 1-Extrapulmonary TB, 39-No AFB investigation requested, 15-Absence TB 
diagnosis information. 
*** 31-Observations were duplicates 
****8-Negative time interval to TB diagnosis, 2-Too long time interval to TB diagnosis (>4years), 3-No 
information about TB diagnosis date. 
FIGURE 2: Study participant’s flow chart 
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 2.5 Measurement and data sources 
A questionnaire was used to capture data from patient’s medical records. 
Outcome variable was diagnostic delay (Defined as PTB diagnosis after 8 weeks, 
from clinical suspicion of PTB). 
Explanatory variables were: 
- Socio-demographic factors; Age, Gender, Marital status, Cigarette 
smoking, Alcohol drinking, Education level, Occupation status, Main 
material walls of house, Number of people in household. 
- Clinical factors; Presenting symptoms, How was the diagnosis made, 
WHO-HIV clinical stage, CD4 counts, BMI, Viral load, ART duration, TB 
prophylaxis, Previous TB diagnosis and TB treatment outcome 
 
2.6 Data management 
Data entry was done using Epi info version 3.5.1. The created dataset was 
transferred to STATA 11 to check for the data completeness, outliers and 
missing data. STATA 11 was also used for categorizing variables and statistical 
analysis.  
 
 
 
 2.7 Data analysis 
Descriptive statistics 
Frequency distributions were used for categorical variables, means and standard 
deviation for continuous variables.  
Inferential statistics 
Chi-square test was used for bivariate analysis as all variables were categorized. 
For those variables with observed frequency less than five fisher’s exact test was 
applied. A factor was considered significant if it had a p-value of ≤ 0.1. Variables 
that demonstrated significant bivariate association (defined as p ≤ 0.1) with PTB 
diagnosis delay were entered into the unconditional logistic regression model to 
assess independent effects. Variables were retained in the final model if they 
demonstrated significant independent association (defined as p ≤ 0.1) with PTB 
diagnosis delay. Parameter of measurement to assess association was Odds 
ratio. 
2.8 Ethical considerations 
Ethical approval for the study was obtained from the University of 
WitwatersrandResearch and Ethics Committee, Johannesburg (ethics clearance 
number M10946; appendix 1). Permission to use the data was granted by the 
Director of Rural AIDS and Development Action Research Programme (RADAR). 
Confidentiality was maintained by not displaying patient names and their medical 
 Confidentiality was maintained by not displaying patient names and their medical 
test results.  
 
CHAPTER THREE 
RESULTS 
This chapter provides the results of findings of a study to determine factors 
associated with delayed pulmonary tuberculosis diagnosis among HIV-infected 
pulmonary tuberculosis suspects in a rural HIV clinic in South Africa. Knowing 
factors associated with time to pulmonary tuberculosis diagnosis is crucial in 
planning control of tuberculosis in the population. 
 
3.1 Descriptive Analysis 
There were 452 study participants. 
 
3.1.1 Demographic characteristics of study participants 
The age of the participants ranged from 23 to 96 years with a mean age of 42.8 
years and a standard deviation of 10.4. Sixty nine percent of participants were 
between 31 to 50 years, 22% were older than 50 years and 9% were between 18 
to 30 years old. Seventy percents of participants (318/452) were females and 
thirty percent (134/452) were males (Figure 3). 
  
 
Figure 3: Distribution of study participants by gender 
 
 
3.1.2 Socio-economic characteristics of study participants 
Thirty nine percent of participants were single, 42.4% had been to primary 
school. More than half of participants (58.1%) were unemployed and not willing 
to work, 80% of participants were not cigarette smokers and 80% were not 
alcohol drinkers. Half of study participants had their houses made of block 
cement and there were one to five people in each household (Table 1). 
 
 
Female 
70% 
Male  
30% 
Female Male
Distribution be sex
 Table 1: Frequency distribution of socio-economic characteristics of study 
participants 
Variable Number Percent (%) 
Marital Status 
Divorced 
Married 
Never Married 
Widowed 
Missing 
 
 
81 
131 
175 
59 
6 
 
18.2 
29.4 
39.2 
13.2 
1.3 
Education level 
No education 
Primary 
Secondary 
Tertiary 
Missing 
 
 
90 
191 
152 
14 
5 
 
20.1 
42.7 
34.0 
3.1 
1.1 
Occupation status 
Salaried worker 
Unemployed and willing to 
work 
Unemployed and not willing 
to work 
Missing 
 
 
46 
 
142 
 
261 
3 
 
10.2 
 
31.6 
 
58.1 
0.7            
Smoke Cigarette 
No 
Yes 
Missing 
 
 
359 
86 
7 
 
80.7 
19.3 
1.5 
Alcohol drinking 
No 
Yes 
Missing 
 
 
355 
89 
8 
 
79.9 
20.1 
1.8 
Main material walls of 
house 
Block cement 
Brick 
Mud 
Wood 
Missing 
 
 
 
                229 
                115 
                104 
                  1 
3 
 
 
51 
25.6 
23.2 
0.2 
0.7 
People in households 
1 to 5 
6 to 10 
>10 
Missing 
 
                                     239 
                                     187 
                                      24 
                                       2 
 
                                    53.1 
                                    41.6 
                                      5.3 
                                      0.4 
 
 
 
 3.2 PTB diagnosis 
Pulmonary tuberculosis was diagnosed in162/452 (35.8%) of the study 
participants. The diagnosis was made by clinical history and chest x-ray in 
38/162 (23.5%) participants, sputum smear positive in 40/162 (24.7%) 
participants and 84/162 (51.9%) by smear negative but culture positive. 
 
3.2.1 TB diagnosis delay 
Pulmonary tuberculosis diagnosis delay was observed among 78/162 (48.15%) 
participants. Median delay was 55 days (IQR = 20 – 302). The delay was 
between 1 to 30 days in 27/78 (34.62%) participants, between 31 to 180 days in 
26/78 (33.33%) participants and 25/78 (32.05%) participants remained 
undiagnosed for more than 180 days. Majority of participants with diagnosis 
delay, 47/78 (60.3%) had their diagnosis made by sputum culture (Table 2). 
 
Table 2: Diagnosis delay duration by method of diagnosis 
Method of TB 
diagnosis 
1 to 30 
days delay  
Number 
(%) 
31 to 180 
days delay 
Number 
(%) 
> 180 days 
delay 
Number 
(%) 
TOTAL 
Number 
(%) 
P-value 
Clinical history 
& chest X-ray 
 
4 (15.3) 5 (19.2) 10 (40) 19 (24.7)  
Sputum smear 
positive 
 
3 (11.5) 2 (7.7) 7 (28) 12 (15.6) 0.016 
Sputum culture 
 
20 (74.1) 19 (73.1) 8 (32) 47 (60.3)  
TOTAL 27 (100) 26 (100) 25 (100) 78 (100)  
 
 3.3 Bivariate analysis 
The difference in the distribution of factors associated with TB diagnosis delay in 
this study was determined using chi square test. For those variables with 
observed frequency less than five fisher’s exact test was applied. A factor was 
considered significant if it had a p-value of ≤ 0.1. The following factors were 
significantly associated with TB diagnosis delay: Patient’s age (p-value 0.006), 
method of TB diagnosis (p-value 0.025), viral load (p-value 0.018) and ART use 
at the time of PTB diagnosis (p-value 0.000). 
There was no statistically significant difference when comparing factors 
association with TB diagnosis delay across gender, marital status, occupation, 
education level, main material walls of house, number of people in households, 
WHO HIV clinical stage, CD4 count, body mass index, cigarette smoking, alcohol 
drinking, previous TB diagnosis, presenting symptoms, TB prophylaxis and TB 
treatment outcome (p-value > 0.1). Table 3 and table 4, summarises the results 
of the bivariate analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 3: Comparison of socio-demographic factors of participants with TB 
diagnosis delay 
Variable Diagnosis delay 
Number (%) 
No delay 
Number (%) 
    P – value 
Patient age 
18 to 40years 
>40years 
 
33(42.9) 
44(57.1) 
      
 
54(64.3) 
30(35.7) 
 
 
 
0.006** 
Sex 
Female 
Male 
 
 
49(62.8) 
29(37.1) 
 
 
58(69.0) 
26(30.9) 
 
 
0.403 
Marital Status 
Divorced 
Married 
Never Married 
Widowed 
 
 
13(16.8) 
25(32.4) 
27(35.0) 
12(15.5) 
 
 
13(15.4) 
21(25.0 
 38(45.2) 
 12(14.2) 
 
 
0.592 
Occupation status 
Salaried worker 
Unemployed and 
willing to work 
Unemployed and not 
willing to work 
 
 
9(11.6) 
 
21(27.2) 
 
47(61.0) 
 
7(8.3) 
 
29(34.5) 
 
48(57.1) 
 
 
 
0.538 
Smoke Cigarette 
No 
Yes 
 
 
57(74.0) 
20(25.9) 
 
66(79.5) 
17(21.4) 
 
 
0.410 
Alcohol drinking 
No 
Yes 
 
 
57(74.0) 
20(25.9) 
 
65(79.2) 
17(20.7) 
 
 
0.434 
Education level 
No education 
Primary 
Secondary 
Tertiary 
 
16(20.8) 
37(48.0) 
23(29.8) 
1(1.3) 
 
 
14(16.7) 
33(39.2) 
33(39.3) 
4(4.8) 
 
 
 
 
   0.320  
Main material walls 
of house 
Block cement 
Brick 
Mud 
 
 
 
38(48.7) 
19(24.3) 
21(26.9) 
 
 
47(55.9) 
22(26.2) 
15(17.9) 
 
 
 
0.377 
Number of people 
in households 
1 to 5 
6 to 10 
>10 
 
 
44(57.1) 
30(38.9) 
3(3.9) 
 
 
46(54.8) 
33(39.3) 
5(5.9) 
 
 
 
  0.895  
NOTE: ** p-value ≤ 0.1 
 
 
 Table 4: Comparison of clinical factors of participants with TB diagnosis 
delay 
Variable Diagnosis delay 
Number (%) 
No delay 
Number (%) 
P – value 
 
Method of TB 
diagnosis 
Clinical History & CXR 
Sputum smear positive 
Smear negative, Culture 
positive 
 
 
 
                    
19(24.1)     
   12(15.2) 
 
48(60.8) 
 
 
                    
19(22.9) 
     28(33.7) 
 
36(43.4) 
 
 
          
0.018** 
WHO-HIV Clinical 
stage 
1 
2 
3 
4 
 
 
                       
2(3.6) 
9(16.4) 
42(76.4) 
2(3.6) 
 
                       
2(2.9) 
16(23.5) 
44(64.7) 
6(8.8) 
 
                        
1.000  
CD4 Count 
(cells/mm3) 
<50 
50 - 200 
>200 
 
 
                   
4(6.9) 
15(25.9) 
39(67.2) 
 
                       
1(1.8) 
10(17.9) 
45(80.4) 
 
                        
0.193  
Viral load (copies/ml) 
<400 
>400 
 
 
      31(60.8) 
20(39.2) 
 
     39(81.2) 
9(18.7) 
 
     0.025** 
BMI 
Underweight 
Normal weight 
Overweight 
Obese 
 
 
16(25.4) 
34(53.9) 
12(19.0) 
1(1.5) 
 
15(22.4) 
38(56.7) 
11(16.4) 
3(4.5) 
 
                        
0.828  
ART use at PTB 
diagnosis 
No 
Yes 
 
 
 
38(50.0) 
38(50.0) 
 
 
62(77.6) 
18(22.5) 
 
 
      0.000** 
 
TB treatment outcome 
Completed treatment 
Died 
Lost to follow up 
Still on treatment 
              
 
                    
41(53.9) 
7(9.2) 
      14(18.4) 
      14(18.4) 
      
 
                    
45(54.9) 
7(8.5) 
 20(24.4) 
     10(12.2) 
       
 
                        
0.640 
NOTE: ** p-value ≤ 0.1 
 
 
 
 3.4 Inferential statistics 
3.4.1 Univariate Logistic regression 
Variables with p-value ≤ 0.1 in bivariate analysis were considered significant 
hence were evaluated further in the univariate unconditional logistic regression 
model to assess independent association with TB diagnosis delay. The 
association between method of TB diagnosis and TB diagnosis delay was not 
statistically significant after univariate logistic regression analysis. 
Therefore patient’s age, viral load and ART use at PTB diagnosis were retained 
in the final multivariate logistic regression model. The results are summarised in 
table 5. 
 
Table 5: Univariate logistic regression results 
Variable Univariate 
OR, 95%CI, P-value 
Patient age 
18 to 40years 
>40years 
 
 
1 
2.4 (1.27 - 4.53) 0.007 
Method of TB diagnosis 
Clinical History & CXR 
Sputum  smear positive 
Smear negative, Culture positive 
 
 
1 
0.43 (0.17 - 1.08) 0.074 
1.33 (0.62 - 2.88) 0.463 
Viral load (copies/ml) 
<400 
>400 
 
 
1 
2.79 (1.12 - 6.99) 0.03 
ART use at PTB diagnosis 
No 
Yes 
 
1 
3.44 (1.73 - 6.87) 0.000 
NOTE: OR is Odds Ratio,   CI is Confidence Interval 
 
 
 3.4.2 Multivariate Logistic regression 
Patient’s age, viral load and ART use at PTB diagnosis remained statistically 
significant after multivariate logistic regression analysis. Patients older than 40 
years have 3.43 times greater risk of TB diagnosis delay compared to those of 
age group 18 to 40 years. The risk of TB diagnosis delay was 3.13 times greater 
in those with viral load greater than 400 copies/ml compared to those with viral 
load less than 400 copies/ml. Those who were on ART at the time of PTB 
diagnosis were 4 times greater risk of TB diagnosis delay compared to those who 
were not on ART at the time of PTB diagnosis. The results are shown in table 6. 
 
Table 6: Multivariate logistic regression results 
Variable Multivariate 
OR, 95%CI, P-value 
Patient age 
18 to 40years 
>40years 
 
 
1 
3.43 (1.38 - 8.55) 0.008 
Viral load (copies/ml) 
<400 
>400 
 
 
1 
3.13 (1.13 - 8.71) 0.03 
ART use at PTB diagnosis 
No 
Yes 
 
1 
4.19 (1.66 - 10.58) 0.002 
NOTE: OR is Odds Ratio,   CI is Confidence Interval 
 
In summary, the results of this analysis revealed that patient age, viral load and 
ART use at the time of PTB diagnosis are significantly associated with TB 
diagnosis delay. 
 
 CHAPTER FOUR 
 
4.1 DISCUSSION 
The aim of this study was to investigate factors associated with PTB diagnosis 
delay among HIV-infected pulmonary tuberculosis suspects in a rural HIV clinic in 
South Africa.  
The following factors were found to be significant correlates of PTB diagnosis 
delay in HIV infected patients in univariate and multivariate analysis: Patient’s 
age, viral load and ART use at the time of PTB diagnosis.  
The risk of TB diagnosis delay was greater in those older than 40 years, those 
with viral load greater than 400 copies/ml and those who were on ART at the 
time of PTB diagnosis. 
 
4.1.1 TB diagnosis delay time 
In our study the median TB diagnosis delay was 55 days which is almost similar 
to findings reported in most studies conducted in other African countries. Median 
diagnostic delays of 15, 12 and 9 weeks, have been reported in studies from 
Tanzania, Uganda and Zambia respectively (21-23). These are poor resource 
countries therefore; TB diagnostic facilities in these countries may be similar to 
those in rural South African settings. The study by Pronyk et al (2001), conducted 
in the same community as this study, found a median total delay to 
 hospitalization of 10 weeks (29), whereas Meintjes et al (28) in Cape Town found 
a median delay of 30 days, which is shorter than the delay found in this study. 
The Cape Town study was conducted at a secondary level hospital, where 
diagnostic facilities are expected to be much better than those in rural setting.  
Health facilities in rural settings are more likely to be having poorly trained 
personnel and limited diagnostic facilities contributing to delay in TB diagnosis, 
as it has been reported by Tatek et al (27) study in Ethiopia.  
In this study 25/78 (32.1%) PTB patients remained undiagnosed and were not 
started on treatment for more than 6 months; this can lead to poorer health 
outcomes in TB/HIV infected patients because tuberculosis accelerates the 
progression of HIV disease (6). A national study done in Malawi found 40% of 
death occurred during the first month of anti-tuberculosis treatment, the reason 
suggested in that study was long delays in diagnosis and initiation of TB 
treatment (54). 
 
4.1.2 Socio-demographic factors 
Similar to the findings of most other studies, TB diagnosis delay was found to be 
significantly associated with patient’s age. Older patients > 40years were at much 
higher risk of TB diagnosis delay compared to those younger than 40years. 
Elderly patients often have other co-existing medical conditions, which makes it 
difficult to diagnose TB in these patients resulting in diagnosis and treatment 
delay (14-16, 23, 26).   
 There was no association between sex and TB diagnosis delay in this study, 
which may be because the majority of the study participants (70%) were females. 
However several other studies have found longer delay to be associated with 
female gender, due to their heavy workload, lack of independence, lack of 
decision making, and fear of divorce or abandonment (18-22). 
Level of education had no significant effect on TB diagnosis delay in this study 
similar to findings in Uganda (22). However several other studies have found 
association between level of education and delayed diagnosis, as it has been 
demonstrated in studies from Tanzania, India, Vietnam and China (31, 20, 30, 
18), that patients with low education and knowledge about the disease are more 
likely to postpone care seeking and visit traditional healers rather than a 
recognized health facilities. 
Number of people in households had no association with TB diagnosis delay in 
this study, however previous study done in the same community as this study, 
revealed people who came from larger households had significantly shorter 
delays, reason being substantial influence of family members in motivating health 
seeking behaviour (29). 
 
 
 
 
 4.1.3 Clinical factors 
PTB diagnosis in this study was predominantly by sputum culture (51.9%), and 
the diagnosis could not be made by chest radiography or sputum smear in most 
of the patients. This is likely because the study was conducted among HIV 
infected patients, studies have reported reduced diagnostic sensitivity of sputum 
smears and chest radiography in HIV infected patients (9, 55). Patients with early 
HIV tend to have the classic clinical and radiographic manifestations of TB seen 
in HIV-negative population, tuberculosis in patients with advanced AIDS may 
present differently.  
High viral load was associated with TB diagnosis delay in this study. Studies 
have shown that, mycobacterium tuberculosis can accelerate the clinical course 
of HIV disease (39-40), resulting in HIV/AIDS progression and hence high viral 
load and low CD4 counts. However, there was no association between patient’s 
CD4 count and TB diagnosis delay in this study.   
In this study 47/78 (60.3%) patients who had sputum smear negative but culture 
positive, had their TB diagnosis delayed. Studies have shown that patients with 
smear negative, culture positive pulmonary TB are capable of transmitting 
mycobacterium tuberculosis to other persons and subsequent development of 
active TB (56-57). Among sputum smear positive patients 12/78 (15.6%) had 
their TB diagnosis delayed. These are very infectious and it is estimated that, 
untreated sputum smear positive case infect up to 15 other individual each year, 
and are important factor in the occurrence of nosocomial  outbreaks of TB (7, 
 58). This can also be a risk factor for the outbreak of Multi-drug resistant TB 
(MDR-TB) and Extensively drug resistant TB (EDR-TB) in this HIV clinic, like 
what happened in Tegera Ferry, South Africa (50). Initial outbreak in Tugera 
Ferry evolved locally and was spread to other patients at the hospital filled with 
people with HIV.  
Timely diagnosis of TB is particularly crucial to minimize disease transmission, 
reduce morbidity and mortality in the community, as well as within health care 
facilities. There is a need for adoption of rapid tests for diagnosing TB like, new 
rapid molecular diagnostics, including the Gene Expert technologies which has 
very high sensitivity and provides a TB diagnosis within 2 hours in those with 
smear positive disease (59). This is an ideal solution to overcome the problem of 
high rates of undiagnosed prevalent TB-HIV in Sub-Saharan African countries. 
 
4.1.4 ART use at the time of PTB diagnosis 
Those who were on antiretroviral therapy at the time of TB diagnosis in this study 
were more likely to delay than those who were not on antiretroviral therapy.This 
provides evidence that there is a delay in TB diagnosis among ART patients in 
this HIV clinic. This can lead to high mortality among patients on ART, as it has 
been reported in a previous study conducted within the same study setting as 
this study, in which they noted a high TB related mortality among ART patients 
(44). High TB related mortality among ART patients was also reported in Haiti 
(60). 
 4.1.5 Study limitations 
In considering the findings of this study it is important to bear in mind the 
following limitations: 
- The study involved patients who were seen at one ARV clinic, thus limiting 
generalisability of these findings to patients treated in other health centers. 
- This is hospital based study cannot provide information on individuals who 
were never treated in hospital and who may die untreated in the 
community. 
- The study included patients who were18 years and above, so it is difficult 
to generalize the results of this study in those who are below 18 years. 
- It only included patients with known HIV positive status and therefore it is 
not necessarily representative of delays experienced by patients with 
unknown HIV positive status. 
- The use of secondary data, this relies on the accuracy of written records, it 
is difficult to control for information bias. 
- Some important factors were not assessed; like diagnostic facilities, 
availability of trained staffs in the health care facility, the quality of services 
provided by the health care facility and effectiveness of staff’s supervision. 
The delay in diagnosis may be due to these factors but were not 
assessed. 
 - The study had relatively small sample size when comparing delay to no 
delay in diagnosis. This might in part account for some of the non 
significant associations observed. 
 
4.2 CONCLUSION 
There is a considerable delay from PTB suspicion to diagnosis in rural HIV-
infected patients. Older patients, those with elevated viral load and those on ART 
at the time of TB diagnosis are at much greater risk of PTB diagnosis delay. This 
delay may lead to the spread of TB within the community and poorer health 
outcomes for those living with HIV/AIDS. 
Given challenges of identifying TB in HIV infected population it is important for 
clinicians caring for patients with HIV to be familiar with the presentation of PTB 
in HIV/AIDS patients and to evaluate suspected cases quickly and 
systematically. Therefore active and collaborative efforts to reduce the PTB 
diagnosis delay are very essential. 
 
 
 
 
 
 4.3 RECOMMENDATIONS  
• Recognizing the difficulty of diagnosing TB in HIV patients and delays 
demonstrated in this study, more rapid tests for TB diagnosis, like rapid 
molecular diagnostics including Gene Expert technologies (59), would be 
recommended. They should be promoted and rolled out to reach areas 
such as this clinic. 
 
• Emphasis on proper and quick PTB investigation should be done on both 
groups of PTB suspects including those on ART and those who are not on 
ART in HIV clinics. 
 
• Regular health education to HIV/AIDS patients about PTB symptoms and 
the importance of early diagnosis and treatment, and regular training of 
health care staff caring for TB/HIV patients. 
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